Literature DB >> 10908312

Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c.

R Yu1, S Mandlekar, A N Kong.   

Abstract

Butylated hydroxyanisole (BHA), a commonly used food preservative, is reported to have anticarcinogenic properties in some animal models. However, the use of BHA as a chemopreventive agent against cancer in human has been challenged by the observation that BHA may exert toxic effect in some tissues of animals. Therefore, it is of great significance to understand the mechanism of BHA-induced toxicity. Here, we report that BHA induces apoptosis in freshly isolated rat hepatocytes. Treatment of hepatocytes with BHA also induced loss of mitochondrial transmembrane potential (Deltapsi(m)), cytochrome c, and activation of caspase-3, -8, and -9 but not caspase-1. Pretreatment with cyclosporin A, an agent that stabilizes mitochondrial permeability transition pore, inhibited BHA-induced loss of Deltapsi(m), cytochrome c release, caspase activation, and apoptosis. Interestingly, benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone failed to prevent these mitochondrial events, although it blocked caspase activation and apoptosis. Furthermore, BHA-induced apoptosis appeared to be independent of formation of reactive intermediates, as evidenced by the lack of effects of antioxidants N-acetyl-L-cysteine and ascorbic acid. Indeed, direct incubation of BHA with isolated mitochondria triggered cytochrome c release. Thus, these results indicate that the cytotoxicity of BHA is due to the induction of apoptosis that is mediated by the direct release of cytochrome c and the subsequent activation of caspases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908312     DOI: 10.1124/mol.58.2.431

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes.

Authors:  Young-Sam Keum; Yong-Hae Han; Celine Liew; Jung-Hwan Kim; Changjiang Xu; Xiaoling Yuan; Michael P Shakarjian; Saeho Chong; Ah-Ng Kong
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

2.  Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.

Authors:  Sujit Nair; Changjiang Xu; Guoxiang Shen; Vidya Hebbar; Avantika Gopalakrishnan; Rong Hu; Mohit Raja Jain; Wen Lin; Young-Sam Keum; Celine Liew; Jefferson Y Chan; Ah-Ng Tony Kong
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Butylated hydroxyanisole inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis and GSH depletion.

Authors:  Hwa Jin Moon; Woo Hyun Park
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

4.  Synthesis, extrusion and rheological behaviour of PU/HA composites for biomedical applications.

Authors:  H B Machado; Rui N Correia; J A Covas
Journal:  J Mater Sci Mater Med       Date:  2010-04-20       Impact factor: 3.896

5.  Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries.

Authors:  Xiao-ming Liu; Mohammed A Azam; Kelly J Peyton; Diana Ensenat; Amit N Keswani; Hong Wang; William Durante
Journal:  Cardiovasc Res       Date:  2007-01-27       Impact factor: 10.787

Review 6.  Comparative meta-analysis of organic contaminants in sewage sludge from the United States and China.

Authors:  Joshua C Steele; Xiang-Zhou Meng; Arjun K Venkatesan; Rolf U Halden
Journal:  Sci Total Environ       Date:  2022-01-25       Impact factor: 7.963

7.  Evaluation of antioxidant activities of ampelopsin and its protective effect in lipopolysaccharide-induced oxidative stress piglets.

Authors:  Xiang Hou; Jingfei Zhang; Hussain Ahmad; Hao Zhang; Ziwei Xu; Tian Wang
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.